11:09 AM
 | 
Dec 14, 2018
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Mission Bio raises $30M series B to expand Tapestri’s reach

Precision genomics company Mission Bio Inc. (South San Francisco, Calif.) raised $30 million on Dec. 13 in an untranched series B round from Agilent Technologies (NYSE:A), Cota Capital, Laboratory...

Read the full 122 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >